Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference39 articles.
1. Ratanatharathorn V, Uberti J, Karanes C, et al.: Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 1994, 84:1050–1055. One of the only prospective randomized trials comparing autologous and standard allogeneic stem cell transplantation for lymphoid malignancies. The authors demonstrate a significantly higher probability of disease progression in the autologous group, thus supporting the existence of GVL benefit with allogeneic transplantation.
2. van Besien K, Thall P, Korbling M, et al.: Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients. Biol Blood Marrow Transplant 1997, 3:150–156.
3. van Besien KW, de Lima M, Giralt SA, et al.: Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplant 1997, 19:977–982.
4. Mandigers CM, Verdonck LF, Meijerink JP, et al.: Graftversus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation. Bone Marrow Transplant 2003, 32:1159–1163.
5. van Besien K, Smith S, Anastasi J, et al.: Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection. Blood 2004, 102:4373–4374.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献